We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.62B
AUM Growth
-$2.78B
Cap. Flow
-$739M
Cap. Flow %
-13.15%
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$70.6M
2
IMVT icon
Immunovant
IMVT
+$56.5M
3
XRAY icon
Dentsply Sirona
XRAY
+$53.6M
4
GEHC icon
GE HealthCare
GEHC
+$53.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$51.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.19%
2 Healthcare 38.27%
3 Technology 7.29%
4 Consumer Discretionary 4.25%
5 Communication Services 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMTC icon
126
Semtech
SMTC
$12.2B
$4.76M 0.08%
+61,891
New +$5.09M
STX icon
127
Seagate
STX
$188B
$4.58M 0.08%
11,683
-7,909
-40% -$3.02M
ESLA icon
128
Estrella Immunopharma
ESLA
$30.7M
$4.34M 0.08%
+4,099,000
New +$4.71M
NTLA icon
129
Intellia Therapeutics
NTLA
$1.8B
$4.31M 0.08%
336,000
-820,000
-71% -$10.4M
PRTA icon
130
Prothena Corp
PRTA
$479M
$4.27M 0.08%
439,411
-1,060,589
-71% -$9.72M
LITE icon
131
Lumentum
LITE
$80.3B
$4.26M 0.08%
+6,065
New +$3.33M
GLW icon
132
Corning
GLW
$128B
$4.18M 0.07%
30,757
+28,252
+1,128% +$3.41M
KEYS icon
133
Keysight
KEYS
$54.5B
$4.16M 0.07%
+14,717
New +$3.69M
LEVI icon
134
Levi Strauss
LEVI
$8.19B
$4.03M 0.07%
218,000
+33,000
+18% +$676K
MTSI icon
135
MACOM Technology Solutions
MTSI
$20.3B
$3.73M 0.07%
+16,808
New +$3.75M
SNDK
136
Sandisk
SNDK
$217B
$3.72M 0.07%
5,850
+4,853
+487% +$2.74M
MCD icon
137
McDonald's
MCD
$188B
$3.58M 0.06%
11,527
-5,389
-32% -$1.72M
CRBP icon
138
Corbus Pharmaceuticals
CRBP
$211M
$3.42M 0.06%
364,000
-172,000
-32% -$1.45M
ELF icon
139
e.l.f. Beauty
ELF
$6.14B
$3.36M 0.06%
55,426
-602,557
-92% -$49M
BBY icon
140
Best Buy
BBY
$17.4B
$3.31M 0.06%
51,631
-44,856
-46% -$2.94M
FIX icon
141
Comfort Systems
FIX
$53.5B
$3.25M 0.06%
2,356
+2,043
+653% +$2.59M
AMD icon
142
Advanced Micro Devices
AMD
$760B
$3.17M 0.06%
15,600
-31,103
-67% -$6.64M
CIEN icon
143
Ciena
CIEN
$53.6B
$3.16M 0.06%
8,140
-2,260
-22% -$691K
ASML icon
144
ASML
ASML
$651B
$3.04M 0.05%
+2,300
New +$3.15M
ONTO icon
145
Onto Innovation
ONTO
$16.6B
$2.85M 0.05%
+13,921
New +$2.85M
VRCA icon
146
Verrica Pharmaceuticals
VRCA
$97.7M
$2.74M 0.05%
518,181
-600,744
-54% -$3.85M
KYNB
147
Kyntra Bio
KYNB
$32.5M
$2.71M 0.05%
400,000
LOW icon
148
Lowe's Companies
LOW
$117B
$2.63M 0.05%
11,117
-5,672
-34% -$1.48M
TSEM icon
149
Tower Semiconductor
TSEM
$23.5B
$2.61M 0.05%
14,880
-8,641
-37% -$1.16M
VSXY
150
Victoria's Secret
VSXY
$6.98B
$2.58M 0.05%
55,693
+2,380
+4% +$133K

Similar funds

Armistice Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $739M in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, down from 51% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.

  • Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
  • Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
  • Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
  • Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
  • Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
  • Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.